Studies in some animal models, such as mice mutant in Fmr1 or MeCP2 (the gene for methyl CpG binding protein 2, mutated in Rett syndrome), have even suggested possible new therapies based on detailed understanding of the biochemical pathology [119-121]. Here, MECP2 is linked to atypical Rett syndrome.